Don't Ignore the Warning Signs of Cancer, Even During a Pandemic

Video

Even amid stay at home orders to mitigate the spread of the coronavirus, listen to your body and speak to your healthcare professionals when you are worried about a potential for cancer.

While healthcare systems may be inundated with COVID-19-related traffic, it’s still important to see a doctor if you notice any signs or symptoms that could point to cancer, says Diane Zipursky Quale, co-founder of the Bladder Cancer Advocacy Network (BCAN).

When asked for advice on how to navigate the pandemic in an interview with CURE®, Zipursky stressed the importance of staying the course to avoid COVID infection and followed up with a reminder that cancer screening remains a crucial tool in staying healthy as well.

“Just because of COVID-19, we cannot forget about the other things that are of great medical concern,” Zipursky said. “Listen to your body, don’t be afraid to reach out and talk to your doctor. They will weigh the risks and the benefits and do what’s best for you.”

Transcription:

I would say listen to the healthcare professionals. The stay-at-home orders, I think, work. Do what you’re supposed to do in terms of washing your hands and using the disinfectants and using a mask and social distance, social distance, social distance (laughs).

One thing I also want to say because I think it’s of great concern both in the bladder cancer field but I think also in the healthcare field itself: if you are not feeling well, if you haven’t even been diagnosed with bladder cancer but you see blood in your urine, don’t be afraid to see a doctor.

Just because of COVID-19, we cannot forget about the other things that are of great medical concern. There is a little bit of concern for people who are showing signs of cancer — showing signs of bladder cancer – and are reluctant to see a doctor. And we know, just as with anything, the sooner you get diagnosed, the sooner you can get treatment, the better your options are, and the better your prognosis is. Listen to your body, don’t be afraid to reach out and talk to your doctor. They will weigh the risks and the benefits and do what’s best for you.

The last thing to know is to take life one day at a time. We will get through this, and we will get through this together. Please don’t hesitate to reach out to all of us at the BCAN community, for the resources and the support that you need. It’s a difficult time for all, but I do believe that we are all resilient and we are all strong, and together we will all get through this.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE